PL2662073T3 - Wstrzykiwanie oktreotydu - Google Patents

Wstrzykiwanie oktreotydu

Info

Publication number
PL2662073T3
PL2662073T3 PL13167187T PL13167187T PL2662073T3 PL 2662073 T3 PL2662073 T3 PL 2662073T3 PL 13167187 T PL13167187 T PL 13167187T PL 13167187 T PL13167187 T PL 13167187T PL 2662073 T3 PL2662073 T3 PL 2662073T3
Authority
PL
Poland
Prior art keywords
octreotide injection
octreotide
injection
Prior art date
Application number
PL13167187T
Other languages
English (en)
Inventor
Shantaram Pawar
Alex George
Prashant Kane
Subhas Bhowmick
Original Assignee
Sun Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Industries Ltd filed Critical Sun Pharmaceutical Industries Ltd
Publication of PL2662073T3 publication Critical patent/PL2662073T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31533—Dosing mechanisms, i.e. setting a dose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/31—Somatostatins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
PL13167187T 2012-05-09 2013-05-09 Wstrzykiwanie oktreotydu PL2662073T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1422MU2012 2012-05-09
EP13167187.7A EP2662073B1 (en) 2012-05-09 2013-05-09 Octreotide Injection

Publications (1)

Publication Number Publication Date
PL2662073T3 true PL2662073T3 (pl) 2018-04-30

Family

ID=48288939

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13167187T PL2662073T3 (pl) 2012-05-09 2013-05-09 Wstrzykiwanie oktreotydu

Country Status (7)

Country Link
US (2) US20130303453A1 (pl)
EP (1) EP2662073B1 (pl)
JP (1) JP2013234184A (pl)
DK (1) DK2662073T3 (pl)
ES (1) ES2659166T3 (pl)
NO (1) NO2662073T3 (pl)
PL (1) PL2662073T3 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200003923A (ko) * 2017-05-15 2020-01-10 썬 파마슈티컬 인더스트리스 리미티드 옥트레오티드 주사제
JP1631211S (pl) 2017-11-06 2019-05-13
USD878567S1 (en) * 2018-07-03 2020-03-17 Haselmeier Ag Medical injector
USD863549S1 (en) * 2018-07-03 2019-10-15 Haselmeier Ag Medical injector
USD878566S1 (en) * 2018-07-03 2020-03-17 Haselmeier Ag Medical injector
EP3811927B8 (en) 2019-10-24 2022-02-23 Sun Pharmaceutical Industries Ltd A stable parenteral dosage form of cetrorelix acetate
US11052196B1 (en) 2020-11-03 2021-07-06 Sun Pharmaceutical Industries Limited Method of injecting octreotide acetate into the body

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU641206B2 (en) * 1991-01-22 1993-09-16 Eli Lilly And Company Multiple dose injection pen
US8110209B2 (en) * 2002-12-20 2012-02-07 Xeris Pharmaceuticals Inc. Intracutaneous injection
WO2005110369A2 (en) * 2004-04-30 2005-11-24 American Pharmaceutical Partners, Inc. Sustained-release microspheres and methods of making and using same
JP2007204391A (ja) * 2006-01-31 2007-08-16 Osaka Medical College モノクロロ酢酸曝露用初期救急処置セット
WO2010115762A1 (en) * 2009-04-01 2010-10-14 Sanofi-Aventis Deutschland Gmbh Pen-type drug delivery device with luminous markers
WO2011104557A1 (en) * 2010-02-24 2011-09-01 Arecor Limited Protein formulations

Also Published As

Publication number Publication date
US20140213984A1 (en) 2014-07-31
US20130303453A1 (en) 2013-11-14
EP2662073B1 (en) 2017-11-08
ES2659166T3 (es) 2018-03-14
NO2662073T3 (pl) 2018-04-07
JP2013234184A (ja) 2013-11-21
EP2662073A1 (en) 2013-11-13
DK2662073T3 (en) 2018-02-12

Similar Documents

Publication Publication Date Title
HK1207997A1 (en) Injection device
TWI561267B (en) Injection device
GB2501897B (en) Injection devices
HK1201484A1 (en) Injection devices
HK1204299A1 (en) Injection device
HK1204297A1 (en) Injection device
HK1205962A1 (en) Injection system
AU349329S (en) Injection device
PT2863968T (pt) Conjunto de injeção
GB201219753D0 (en) Injection devices
AP3655A (en) Improved injections
PL2662073T3 (pl) Wstrzykiwanie oktreotydu
GB2505700B (en) Injection device
HK1206662A1 (en) Injector
EP2865461A4 (en) INJECTION DEVICE
GB201219402D0 (en) Injection device
EP2865462A4 (en) INJECTION DEVICE
EP2851003A4 (en) INJEKTOR
GB201220738D0 (en) Injector
GB201212396D0 (en) Easy Inject